my latest cover illustration with the American Journal of Transplantion!

Long-read metagenomics empowers precise tracking of bacterial strains and their genomic changes after fecal microbiota transplantation www.biorxiv.org/content/10.1101/2024.09.30.615906v1

Long-read metagenomics empowers precise tracking of bacterial strains and their genomic changes after fecal microbiota transplantation https://www.biorxiv.org/content/10.1101/2024.09.30.615906v1

Fecal microbiota transplantation (FMT) has revolutionized the treatment of recurrent Clostridioides

Long-read metagenomics empowers precise tracking of bacterial strains and their genomic changes after fecal microbiota transplantation www.biorxiv.org/content/10.1101/2024.09.30.615906v1

Long-read metagenomics empowers precise tracking of bacterial strains and their genomic changes after fecal microbiota transplantation https://www.biorxiv.org/content/10.1101/2024.09.30.615906v1

Fecal microbiota transplantation (FMT) has revolutionized the treatment of recurrent Clostridioides

Transplantation and old stem cell age independently increase the risk of clonal hematopoiesis in long-term survivors of pediatric HCT www.medrxiv.org/content/10.1101/2024.09.28.24314531v1

Transplantation and old stem cell age independently increase the risk of clonal hematopoiesis in long-term survivors of pediatric HCT https://www.medrxiv.org/content/10.1101/2024.09.28.24314531v1

In pediatric hematopoietic cell transplantation (HCT) recipients, transplanted donor cells may need

Ben j'imagine oui...il était bien rangé entre ton traité sur la thanatopraxie et le guide de la transplantation d'organes !

📃Scientific paper: Oral microbiota transplantation for intra-oral halitosis: a feasibility analysis based on an oral microbiota colonization trial in Wistar rats ➡️ Continued on ES/IODE

Mindestens bis 1 Jahr nach Transplantation bleibt es so. Also bis Mitte/Ende Januar

📃Scientific paper: Safety and efficacy of faecal microbiota transplantation in patients with mild to moderate Parkinson's disease (GUT-PARFECT): a double-blind, placebo-controlled, randomised, phase 2 trial ➡️ Continued on ES/IODE

PEG Adjustment Enables Genome Transplantation Using Mycoplasma Mycoides Recipient www.biorxiv.org/content/10.1101/2024.09.27.615432v1

PEG Adjustment Enables Genome Transplantation Using Mycoplasma Mycoides Recipient https://www.biorxiv.org/content/10.1101/2024.09.27.615432v1

Pioneering advances in synthetic biology, initiated at the J. Craig Venter Institute, have enabled t

PEG Adjustment Enables Genome Transplantation Using Mycoplasma Mycoides Recipient www.biorxiv.org/content/10.1101/2024.09.27.615432v1

PEG Adjustment Enables Genome Transplantation Using Mycoplasma Mycoides Recipient https://www.biorxiv.org/content/10.1101/2024.09.27.615432v1

Pioneering advances in synthetic biology, initiated at the J. Craig Venter Institute, have enabled t